Scientists have revealed that protein molecules in the brain are broken down and replaced at different rates, depending on where in the brain they are.
The study, published in eLife, provides essential insights into how the components of different cells in the brain are altered. These kinds of alterations may be important in our abilities to learn and form memories, especially as protein turnover plays a crucial role in these processes.
Proteins are the mechanical engines of the cell, carrying out many essential functions. The ‘turnover’ of proteins in a cell is balanced by how much protein is manufactured and how much is broken down. Under normal conditions, this turnover is continuous, and ensures that damaged proteins can be removed and replaced by new ones. It also gives a cell the ability to change its entire proteome – all the proteins it contains – to respond quickly to internal and external signals, such as hormones or electrical impulses.
Protein turnover ensures that synapses – the structures that allow an electrical or chemical impulse from one nerve cell to another – remain flexible. This phenomenon, called ‘synaptic plasticity’, is important for maintaining the brain’s ability to create new nerve networks, which in turn allows us to create new memories or learn new behaviours and skills.
“It is known that proteins can show very different turnover rates in different tissues or different cell types of the same organism, but little is known about protein turnover rates in different cell types of the brain, and how they affect each other,” explains lead author Aline Dörrbaum, graduate student at the Max Planck Institute for Brain Research, Germany.
To address this, the team grew cells from the hippocampus region of the brain and used isotopically labelled amino acids (the building blocks of proteins) to determine the ‘half-life’ of proteins. This was measured by how quickly the ‘heavy’-labelled proteins appeared in the cells as the proteins were made, and how quickly the natural ‘light’ proteins disappeared as they were broken down. The team obtained half-life measurements for over 5,100 protein groups from different neuronal culture types that contained a mixture of neurons and glia cells (which support and provide insulation between neurons). All samples contained both neurons and glia cells, but in different proportions.
They found the half-lives varied greatly – from less than a day (fast turnover) to more than 20 days (slow turnover) – and that this depended on the location of the protein in the cell. Proteins nearer the surface of the cell, often involved in communication, were shorter-lived and proteins involved in energy metabolism were longer-lived compared to the overall protein population.
Of particular note, the researchers found that an identical protein expressed in glia cells had a much faster turnover rate than when it was expressed in neuron cells. A subset of proteins also had faster or slower turnover rates when there were more glial cells in the environment.
“Our results demonstrate that both the cell-type of origin as well as the nature of the environment outside the cell have powerful influences on protein turnover,” concludes senior author Professor Erin Schuman, Director of the Max Planck Institute for Brain Research. “Our next goal is to determine how nerve plasticity regulates and exploits turnover to modify the brain proteomes in response to different stimuli.”
Media contacts
Emily Packer
eLife
e.packer@elifesciences.org
+441223855373
About
eLife aims to help scientists accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours in science. We publish important research in all areas of the life and biomedical sciences, which is selected and evaluated by working scientists and made freely available online without delay. eLife also invests in innovation through open source tool development to accelerate research communication and discovery. Our work is guided by the communities we serve. eLife is supported by the Howard Hughes Medical Institute, the Max Planck Society, the Wellcome Trust and the Knut and Alice Wallenberg Foundation. Learn more at https://elifesciences.org.
